KMDS
E-submission
Search
- Page Path
- HOME > Search
Letter to the editor
- Bupropion-Induced Dystonia in a Patient with Parkinson’s Disease
- Monalisa Vegda, Samhita Panda
- J Mov Disord. 2020;13(3):241-243. Published online August 31, 2020
- DOI: https://doi.org/10.14802/jmd.20046
- 10,555 View
- 112 Download
- 2 Web of Science
- 3 Crossref
-
PDF
Supplementary Material -
Citations
Citations to this article as recorded by
- Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database
Rongrong Lu, Ying Jiang, Zhiqiang Du, Qin Zhou, Yuan Shen, Haohao Zhu
Journal of Affective Disorders.2024; 354: 649. CrossRef - Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori, Bernardo Dell’Osso
BMC Neurology.2022;[Epub] CrossRef - Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
Thomas Müller
Journal of Experimental Pharmacology.2021; Volume 13: 397. CrossRef
- Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database
First
Prev
